...
首页> 外文期刊>Disease Prevention Daily. >Studies from University of Kashmir Reveal New Findings on Cancer (Gamma Dose Monitoring To Assess the Excess Lifetime Cancer Risk In Western Himalaya)
【24h】

Studies from University of Kashmir Reveal New Findings on Cancer (Gamma Dose Monitoring To Assess the Excess Lifetime Cancer Risk In Western Himalaya)

机译:克什米尔地区大学的研究揭示新发现癌症(γ剂量监测评估西部过剩一生中罹患癌症的风险喜马拉雅山脉)

获取原文
获取原文并翻译 | 示例
           

摘要

2021 MAY 05 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Current study results on Cancer have been published. According to news originating from Srinagar, India, by NewsRx correspondents, research stated, "The present work focussed on demarcation of areas with cancer development risk through excess lifetime cancer risk (ELCR) by assessing spatial variability of gamma dose in outdoor and indoor environment in western Himalaya." Financial support for this research came from Board of Research in Nuclear Sciences (BRNS). Our news journalists obtained a quote from the research from the University of Kashmir, "Average outdoor gamma dose and outdoor annual effective dose exceed the corresponding world averages. An indoor gamma dose (barring Budgam, Ganderbal and Kashmir University of Kashmir division and Reasi city of Jammu division) also exceed the world average."
机译:2021年5月05 (NewsRx)——由一个新闻记者在疾病预防每日新闻编辑——电流癌症研究结果已经发表。据新闻来自斯利那加,印度NewsRx记者,研究指出,“目前的工作集中在界定的通过过剩领域与癌症发展的风险一生中罹患癌症的风险(ELCR)评估空间在户外和室内γ剂量差别在喜马拉雅西部环境。”对这项研究来自董事会的支持核科学研究(BRNS)。记者引用研究获得大学的克什米尔,“平均户外γ剂量和户外年有效剂量超过相应的世界平均水平。室内γ剂量(除非Budgam, Ganderbal和克什米尔克什米尔分裂和Reasi大学城市查谟部门)也超过世界平均水平。”

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号